Rheumatoid arthritis can show up in blood work, but no single blood test confirms or rules it out. Doctors typically order a combination of tests, and roughly 38% of people with RA test negative on the two most common antibody tests. Blood work is one piece of the diagnostic puzzle, alongside symptoms, physical examination, and imaging.
The Two Main Antibody Tests
The first test most doctors order is rheumatoid factor (RF). This measures an antibody that attacks healthy tissue, and it’s been the standard screening test for decades. The problem is that RF isn’t very accurate on its own. Its sensitivity for RA is only about 28%, meaning it misses the majority of cases. Its specificity is around 85 to 87%, which means roughly 1 in 7 positive results comes from someone who doesn’t actually have RA.
The second and more reliable test is anti-CCP (anti-cyclic citrullinated peptide). This antibody is far more specific to RA. Pooled data from multiple systematic reviews show anti-CCP has a specificity of 95 to 96%, meaning a positive result makes RA very likely. Its sensitivity ranges from 53 to 71%, so it still misses a significant number of cases. A positive anti-CCP is roughly two and a half times more reliable than a positive RF for pointing to RA specifically.
The practical takeaway: a positive anti-CCP result is strong evidence that you have RA. A negative result on either test doesn’t mean you’re in the clear.
What Inflammation Markers Tell You
Alongside antibody tests, doctors check two general markers of inflammation: ESR (erythrocyte sedimentation rate, sometimes called “sed rate”) and CRP (C-reactive protein). People with RA often have elevated levels of both. These tests don’t point specifically to RA. They simply tell your doctor that inflammation is happening somewhere in the body. Infections, other autoimmune conditions, and even obesity can raise these numbers.
Where ESR and CRP become especially useful is in tracking your disease over time. If you’ve already been diagnosed, rising levels can signal a flare, and falling levels suggest your treatment is working. They’re better as a monitoring tool than a diagnostic one.
What a Complete Blood Count Reveals
A standard CBC won’t diagnose RA, but it can show patterns that support the diagnosis. In a study comparing 230 RA patients with 115 healthy controls, people with RA had significantly lower hemoglobin levels (averaging 132 versus 143 g/L), higher neutrophil counts, and higher monocyte counts. Lower hemoglobin reflects anemia of chronic disease, a common companion to RA caused by ongoing inflammation interfering with red blood cell production. Platelet counts, interestingly, were similar between the two groups.
Your doctor may also look at ratios derived from CBC numbers, like the neutrophil-to-lymphocyte ratio, which tends to be markedly higher in RA patients. These ratios aren’t diagnostic on their own but add supporting evidence.
Why Positive RF Doesn’t Always Mean RA
Rheumatoid factor can be elevated in a surprisingly long list of conditions that have nothing to do with RA. These include hepatitis B and C, tuberculosis, HIV, EBV and CMV infections, liver cirrhosis, sarcoidosis, and even malaria. RF can also appear after multiple vaccinations. Perhaps most notably, healthy people over 50 sometimes test positive, and the rate increases with age. Among healthy 70-year-olds, a positive RF is not unusual at all.
This is the main reason anti-CCP has become the preferred antibody test. It’s far less likely to be triggered by infections or aging.
Seronegative RA: When Blood Work Looks Normal
About 38% of people diagnosed with RA are “seronegative,” meaning they test negative for both RF and anti-CCP. This proportion has stayed consistent over time, so it’s not a diagnostic gap that’s shrinking. If your joints are swollen, stiff (especially in the morning for 30 minutes or longer), and symmetrically affected, your doctor may diagnose RA based on clinical findings and imaging even with clean antibody results.
Seronegative RA is real RA. It generally responds to the same treatments, though some research suggests it may follow a slightly different course than seropositive disease.
Blood Work Can Detect RA Before Symptoms Start
One of the more striking findings in recent research is that RA-related antibodies, particularly anti-CCP, can appear in the blood years before joint symptoms develop. A seven-year study tracking people who carried these antibodies found evidence of widespread inflammation, immune cell dysfunction, and cellular reprogramming long before any pain or swelling appeared. RA doesn’t start when symptoms begin. It starts silently, potentially years earlier, and blood work can sometimes catch it in that window.
This matters most for people with a strong family history of RA or those with vague, early symptoms that haven’t yet become full-blown joint disease.
Blood Tests for Monitoring Treatment
Once you’re diagnosed and on treatment, blood work shifts from diagnostic to monitoring. Your doctor will regularly check liver enzymes and kidney function because many RA medications can affect both organs. NSAIDs, disease-modifying drugs, corticosteroids, and biologic therapies all carry some risk of liver or kidney damage. These aren’t tests for RA itself; they’re safety checks to make sure your treatment isn’t causing harm.
A newer monitoring tool called Vectra DA measures 12 different biomarkers and produces a disease activity score on a scale of 1 to 100. It’s designed to give a more complete picture of how active your RA is than standard inflammatory markers alone. This test can be particularly helpful when other pain conditions like fibromyalgia make it hard to tell whether symptoms are coming from RA inflammation or something else. It can also track how well you’re responding to specific medications.
What Blood Work Can and Can’t Do
Blood tests are most useful when they’re positive. A positive anti-CCP makes RA very likely. Elevated RF combined with elevated inflammation markers and matching symptoms paints a convincing picture. But negative blood work doesn’t eliminate RA as a possibility, and positive RF alone doesn’t confirm it.
Doctors diagnose RA by combining blood results with the pattern of joint involvement, duration of morning stiffness, imaging findings (ultrasound or MRI can detect joint inflammation before X-rays show damage), and how symptoms respond over time. Blood work is the starting point, not the finish line.